Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2025 and 2026.
-
Tight liquidity NBB
Cash and receivables cover 5 % of short-term debt in 2026; threshold 65 %.
Financials
Financial year 2026
PHARMA CONSULT LZ from Kortenberg, company number BE0878789514, closed financial year 2026 with a result of € -8,090 after tax. For that financial year PHARMA CONSULT LZ recorded a gross margin of € 18,587 and equity of € 139,116. Compared with financial year 2025, the result moved from € -7,109 to € -8,090. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 139,116
▼ 5% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -8,090
▼ 14 % more loss than in 2025
Profit after tax over the fiscal year.
€ 2,933
▼ 16% vs 2025
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 127,916.
Debts at end 2026
€ 181,035
▼ 14% vs 2025
€ 19,714 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € 27,539 | € 12,759 | € 18,622 | € 18,587 | |
| Profit after taxes | € -612 | € -13,086 | € -7,109 | € -8,090 | ▼ € 981 |
| Equity | € 167,401 | € 154,316 | € 147,206 | € 139,116 | ▼ 5% |
| Total debts | € 269,404 | € 243,930 | € 230,190 | € 225,321 | ▼ 2% |
| Cash | € 48,527 | € 8,769 | € 3,511 | € 2,933 | ▼ 16% |
| Land & buildings | € 386,315 | € 367,111 | € 351,934 | € 336,758 | ▼ 4% |
| Retained profit | € 156,201 | € 143,116 | € 136,006 | € 127,916 | ▼ 6% |
| Bank debt | € 269,355 | € 238,756 | € 210,038 | € 181,035 | ▼ 14% |
| Balance sheet total | € 436,806 | € 398,246 | € 377,396 | € 364,436 | ▼ 3% |
Key figures of PHARMA CONSULT LZ, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
What happened to PHARMA CONSULT LZ?
What happened at PHARMA CONSULT LZ in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: loss of € 8,090. Source: NBB ↗
- New establishment in Kortenberg. KBO
- Start of the company according to the CBE. KBO
In short
From € 612 loss in 2023 to € 8,090 loss in 2026.
A new publication or filing at PHARMA CONSULT LZ? We notify you, reason included.
Follow PHARMA CONSULT LZDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMA CONSULT LZ is Lieven Zwaenepoel. Lieven Zwaenepoel is also behind Brabants Apothekers Forum, OZOS - Optimale Zorg door Optimale Samenwerking and Easytocare.
Directors
According to the 2026 annual accounts
Lieven Zwaenepoel
Director
Also active at: Brabants Apothekers Forum, OZOS - Optimale Zorg door Optimale Samenwerking, Easytocare
Establishments
Establishment units
Physical locations of this company
Curegemstraat 49
3071 Kortenberg
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0878.789.514
- VAT number
- BE 0878.789.514
- Registered office
- Curegemstraat 49, 3071 Kortenberg
- Names & denominations
- PHARMA CONSULT LZ
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 20 January 2006
- Peppol
- Active · Active since 6 Mar 2025
- Contact
- [email protected] 0032485202577